Press Releases Invion Limited

Equities

Delayed Australian S.E. Other stock markets 08:03:57 13/05/2024 am IST			5-day change	1st Jan Change
0.006 ^AUD	+20.00%		0.00%	+20.00%

08/05	Invion Partners with Hanlim Pharma for Glioblastoma Treatment	MT
05/03	Invion's Anti-Cancer Drug Logs Postive Preclinical Trial Results	MT

Invion : Activities Report and Appendix 4C	21/22/21	PU
Invion : Notification regarding unquoted securities - IVX	20/22/20	PU
Invion : Activities Report and Appendix 4C	20/22/20	PU
Invion : Notification regarding unquoted securities - IVX	21/22/21	PU
Invion : Notice of General Meeting/Proxy Form	25/22/25	PU
Invion : Investor Presentation	03/22/03	PU
Invion : Application for quotation of securities - IVX	02/22/02	PU
Invion : Activities Report and Appendix 4C	20/22/20	PU
Invion : Application for quotation of securities - IVX	13/21/13	PU
Invion : Notification regarding unquoted securities - IVX	07/21/07	PU
Invion : Proposed issue of securities - IVX	25/21/25	PU
Invion : Cancel - Proposed issue of securities - IVX	23/21/23	PU
Invion : Proposed issue of securities - IVX	23/21/23	PU
Invion : Prospectus	23/21/23	PU
Invion : Share Purchase Plan Offer Booklet & Application Form	22/21/22	PU
Invion : Application for quotation of securities - IVX	22/21/22	PU
Invion : Proposed issue of securities - IVX	16/21/16	PU
Invion : selects Guilin Xingda to manufacture light-therapy medical equipment	29/19/29	PU
Invion : Collaborates to Develop Powerful Skin Cancer Gel	07/18/07	PU
Invion : spin-off Chronic Airway Therapeutics selects leading CRO for the future development of nadolol	27/18/27	PU

No results for this search